跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45 条关于
“INTASYL”
全部
45
临床试验
5
药物
18
机构
3
资讯
19
去年
Phio Pharmaceuticals' INTASYL Platform Enhances Immune Cell Targeting of Cancer
去年
Phio Pharmaceuticals' PH-762 Shows Complete Tumor Clearance in Skin Cancer Trial
10个月前
Phio Pharmaceuticals Achieves 100% Tumor Clearance in Skin Cancer Trial as FDA Accepts PH-762 Development Protocol
去年
Phio Pharmaceuticals Secures U.S. Manufacturing Partnership for PD-1 Silencing Cancer Therapy PH-762
去年
Phio Pharmaceuticals' Stock Surges Following Promising Cancer Treatment Results
10个月前
Phio Pharmaceuticals Reports Promising Phase 1b Results for PH-762 in Cutaneous Squamous Cell Carcinoma
10个月前
Phio Pharmaceuticals' PH-762 Shows Promising Results in Phase 1b Skin Cancer Trial with 37.5% Complete Response Rate
去年
Phio Pharmaceuticals Completes Enrollment in Phase 1b Trial of PH-762 for Skin Cancers
去年
NPPA Committee Identifies Patent Discrepancies in Intas' Clozapine ER Pricing Application
4个月前
Xbrane and Intas Revise Financing Terms for Opdivo Biosimilar Xdivane Development
第 1 页,共 2 页
上一页
下一页